| News

Genedata accelerating drug development

16.07.2020

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Genedata has developed a platform for managing data from biopharmaceutical research. This platform also allows data to be brought together from different sources and then processed. The announced collaboration with international pharmaceutical and laboratory equipment supplier Thermo Fisher will now enable the direct integration of Thermo Fisher’s robotics and automation platforms with the Genedata Biopharma Platform, as was reported in a Genedata press release.

The two companies will consequently be able to offer scientists a centralized platform that delivers automation systems for sample handling, lab operations and testing and enables them to digitally trace all results for every sample of imported raw instrument data. This will accelerate the discovery and development of next-generation biotherapeutics, the Basel IT company says. Integrating the two platforms gives researchers the power to make data-based decisions and uncover insights not possible before, explained Hansjoerg Hass, Senior Director Lab Automation at Thermo Fisher.

The integration includes both laboratory instruments and software from Thermo Fisher. Both companies are implementing interfaces for the seamless integration of all areas of the two platforms. Genedata has extensive experience in projects of this kind, with the Basel company’s IT solutions having been used by other major players to automate complex laboratory workflows with lab equipment, as Othmar Pfannes, CEO of Genedata, outlines.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Noema Pharma raises 54 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Noema Pharma raises 54 million Swiss francs

The Basel-based pharmaceutical company Noema Pharma has raised a total of 54 million Swiss francs as part of a Series...

Read More
Meteoblue constantly presents new developments
Basel Area Business & Innovation, Innovation, Invest

Meteoblue constantly presents new developments

The meteoblue weather service based in Basel has developed a weather map widget that can be embedded in any website....

Read More
Lonza manufactures coronavirus vaccine for Moderna
Basel Area Business & Innovation, Innovation, Invest

Lonza manufactures coronavirus vaccine for Moderna

Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the...

Read More
Synendos raises 20 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Synendos raises 20 million Swiss francs

Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the...

Read More
Both Basel cantons are first class borrowers
Basel Area Business & Innovation, Invest

Both Basel cantons are first class borrowers

Standard & Poor’s has awarded the canton of Basel-City its top rating of AAA. The rating agency anticipates that Basel...

Read More
ChemAxon establishes subsidiary in Basel
Basel Area Business & Innovation, Innovation, Invest

ChemAxon establishes subsidiary in Basel

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in...

Read More
1 2 3 37

Do you have a question? We'd like to hear from you.